
The collaboration is the latest in a series of partnerships for diabetes care announced by the medical device maker.

The collaboration is the latest in a series of partnerships for diabetes care announced by the medical device maker.

Results from the phase 3 trials will be presented next month at the American Diabetes Association Scientific Sessions in New Orleans.

When providers move from employing traditional practices to new methods that are steeped in evidence, this benefits patient health. The result is higher-quality, more affordable care, often stemming from lower rates of hospital infections, readmissions, and, in general, improved outcomes.

The largest group of endocrinologists first declared obesity a disease in 2012. Guidelines call for making relief of weight-related complications the first priority, not weight loss per se.

Authors from the University of Minnesota College of Pharmacy highlight the role that pharmacists can play in care optimization for seniors with chronic conditions.

Now that Medicare is poised to pay for the Diabetes Prevention Program, the next question is how to make it scalable.

The smallest overall increase in the MMI in 15 years is masked by the fact that employees are bearing an increasingly large share of healthcare costs.

A recent study showed patients with type 2 diabetes did better if given the combination therapy at the outset than if given 1 of the components as monotherapy.

What we're reading, May 23, 2016: Oklahoma governor vetoes bill banning abortion; the FDA approved a new nutrition label highlighting sugar added; and 7 years after death panels, conversations on end-of-life planning are becoming more common.

How does the largest payer in a state with a large senior population respond to the rising need for diabetes care and prevention?

Finding diabetes and treating it early can prevent high healthcare costs in the long term, the authors day.

The updated label reflects research that shows how hard it is to consume key nutrients and maintain calorie limits in a diet overwhelmed by sugar. The label will be a legacy of First Lady Michelle Obama's focus on better nutrition to combat childhood obesity.

The authors discuss a simple strategy for payers to ensure more patients with type 2 diabetes achieve control of A1C.

A recent Diabetes Care study found flaws in Medicare's competitive bidding program for diabetes test strips. Two of that study's co-authors discuss the findings and why CMS should suspend the bidding program.

Right now, islet transplant therapy requires donated cells. The hope is that lab-grown islets could vastly expand the pool of patients who could get treatment.

Telemedicine works well with diabetes because it is a condition that works with a lot of numbers and data, and physicians can look at that data remotely rather than requiring a face-to-face visit, explained David Brumley, MD, MBA, senior medical director at Tufts Health Plan.

Researchers set out to analyze the clinical outcomes in a real-world clinical setting of patients with T2D who switched to Toujeo from another basal insulin.

A new study established the association between variation in state-level health outcomes and the allocation of state spending between healthcare and social services.

The findings are consistent with other results that have shown sizable drops in A1C, as well as the ability to control blood pressure in patients who previously failed to meet targets.

The report highlights insights from experts at the recent meeting, Patient-Centered Diabetes Care. Failing to treat obesity will only cost more later, experts said.

This week, the top managed care stories included an exclusivity deal that has patients with type 1 diabetes unhappy, a report found the healthcare system could have saved $73 billion from greater use of generics, and The American Journal of Managed Care seeks your nominations for an emerging leader award.

Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.

Regeneron's CEO said ICER's methodology wasn't scientific. The nonprofit said analysis of a drug based on what people can afford to pay is the point of its work.

In a statewide telephone survey, patient-reported indicators of the patient-centered medical home correlated with improved process measures in diabetes, cholesterol screening, vaccination, and care access.

The findings show poor diet can have immediate effects on the body, and they suggest ways to overcome them.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
